Navigation Links
FDA Approves Combo Shot for Meningitis, Hib in Kids
Date:6/15/2012

FRIDAY, June 15 (HealthDay News) -- A new combination vaccine that protects children against two potentially deadly bacterial diseases has been approved by the U.S. Food and Drug Administration.

The Menhibrix vaccine is for children ages 6 weeks to 18 months and guards against the bacteria Neisseria meningitidis (meningococcal disease, including bacterial meningitis) and Haemophilus influenzae type b (Hib disease).

These bacteria can cause sepsis by infecting the bloodstream and can cause meningitis by infecting the lining that surrounds the brain and spinal cord. Diseases caused by these bacteria often progress rapidly and can cause death or serious, long-term problems such as blindness, mental retardation or amputations, according to background information provided in an FDA news release.

Early symptoms for both meningococcal and Hib diseases can be difficult to distinguish from other common childhood illnesses, the experts noted.

The FDA approval is based on studies that assessed the effectiveness of the vaccine in several hundred U.S. infants and toddlers and tested the safety of the vaccine in about 7,500 infants and toddlers in the United States, Mexico and Australia.

Common negative side effects included pain, redness and swelling at the injection site, as well as irritability and fever.

Menhibrix is given as a four-dose series at 2, 4, 6 and 12 through 15 months of age. The first dose may be given as early as 6 weeks of age and the fourth dose may be given as late as 18 months of age.

"With today's approval of Menhibrix, there is now a combination vaccine that can be used to prevent potentially life-threatening Hib disease and two types of meningococcal disease in children. It is the first meningococcal vaccine that can be given starting as young as 6 weeks of age," Dr. Karen Midthun, director of the FDA's Center for Biologics Evaluation and Research, said in the news release.

The vaccine is made by GlaxoSmithKline Biologicals.

More information

The U.S. Centers for Disease Control and Prevention has more about meningococcal disease.

-- Robert Preidt

SOURCE: U.S. Food and Drug Administration, news release, June 14, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Approves Generic Versions of Plavix
2. Combo Therapy May Help Ease Ringing in the Ears
3. Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy
4. Two-Drug Combo May Be Safe for Melanoma Treatment
5. Two-Drug Combo Helps Teens With Migraines
6. Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned
7. Experimental Chemo Combo for Colon Cancer Disappoints
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves Combo Shot for Meningitis, Hib in Kids
(Date:8/16/2017)... ... August 16, 2017 , ... Maury Regional Health has announced a large-scale ... broadly deploying AccuVein devices, Maury Regional Medical Center is making vein visualization part of ... a needle stick and more importantly, helps our staff members locate a vein that ...
(Date:8/16/2017)... ... August 16, 2017 , ... With a new PD diagnosis every nine minutes, ... , The grants are awarded through a competitive application process and reviewed by APDA’s ... backgrounds and expertise in all areas relevant to PD research. The SAB meets ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... $5.99, eBook, 9781498499620    ) shares that during the time of a cancer diagnosis, surgery ... of God's love, and all the many ways God shows love to those ...
(Date:8/16/2017)... Lake Orion, Rochester, Michigan (PRWEB) , ... August ... ... now offer treatment options to patients suffering from chronic pelvic pain. In ... treatment of various pelvic pain disorders including endometriosis, menorrhagia (abnormal heavy bleeding during ...
(Date:8/16/2017)... ... August 16, 2017 , ... With low back pain afflicting 8 of 10 Americans at ... kissing cousin – upper back pain. But this equally vexing condition stems from a variety ... Kaixuan Liu, MD, PhD , founder and president of Atlantic Spine Center. , ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO), is now ... residents. Naloxone is available without a ... pharmacy, G-3320 Beecher Road. ... Administration, is intended to block or reverse the effects ... of consciousness. The medication is often carried by first ...
(Date:8/11/2017)... Israel , Aug. 11, 2017 DarioHealth ... with mobile health and big data solutions, today announced ... on Monday, August 14 and host a conference call ... quarter 2017 operating and financial results and its strategy ... will be hosted by Erez Raphael , Chief ...
(Date:8/7/2017)... WARSAW, Ind. , Aug. 7, 2017 Zimmer ... in musculoskeletal healthcare, today announced that its Board of Directors ... stockholders for the third quarter of 2017. ... will be paid on or about October 27, 2017 to ... September 22, 2017.  Future declarations of dividends are subject to ...
Breaking Medicine Technology: